CeraVe Skin Renewing Peptide Cream

CeraVe was developed in 2005 by American dermatologists and researchers who sought to create a line of skincare products focused on repairing and strengthening the skin barrier through essential ceramides. The brand quickly became a staple in dermatological care due to its patented Multivesicular Emulsion (MVE) technology, which releases moisturizing ingredients over 24 hours.

Originally launched by Valeant Pharmaceuticals (now Bausch Health) in the United States, the brand's immense success led to its acquisition by the French beauty conglomerate L'Oréal in 2017. Today, CeraVe is part of L'Oréal's Active Cosmetics division. While it remains deeply rooted in its American heritage with primary manufacturing in the USA, L'Oréal's global infrastructure means that production can occur in several locations worldwide to meet international demand.